Taysha Gene Therapies, Inc. (NASDAQ: TSHA)

$6.22 -0.24 (-3.72%)
As of Apr 21, 2026 03:59 PM
Sector: Healthcare Industry: Biotechnology CIK: 0001806310
Market Cap 1.90 Bn
P/E -17.47
P/S 194.32
Div. Yield 0.00
Total Debt (Qtr) 50.11 Mn
Add ratio to table...

About

Breakdown of Revenue (2024)

Equity Components Breakdown of Revenue (2024)

Peer comparison

Companies in the Biotechnology
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 VRTX Vertex Pharmaceuticals Inc / Ma 111.34 Bn 28.15 9.28 -
2 REGN Regeneron Pharmaceuticals, Inc. 78.06 Bn 17.30 5.44 1.99 Bn
3 ALNY Alnylam Pharmaceuticals, Inc. 41.92 Bn 152.39 13.31 -
4 RVMD Revolution Medicines, Inc. 28.36 Bn -25.11 34,170.56 -
5 ZLAB Zai Lab Ltd 25.77 Bn -147.06 106.30 0.20 Bn
6 MESO Mesoblast Ltd 24.32 Bn -190.54 1,414.27 0.12 Bn
7 MRNA Moderna, Inc. 21.25 Bn -7.52 10.93 0.59 Bn
8 RPRX Royalty Pharma plc 20.83 Bn 27.08 8.76 8.95 Bn